Living with cancer: "good" days and "bad" days--what produces them?
MQOL's reliability and responsiveness suggest it can be used to determine changes in the QOL of groups. The results allow interpretation of changes in MQOL scores with respect to meaning of the change to oncology patients. This in turn is helpful to determine the sample size required in future studies. Some of the domains important to the QOL of oncology patients are not included in widely used measures of QOL.
SCD use in conjunction with vasopressor significantly reduced the incidence of a 20% reduction of MAP.